Bill
Bill > A04054
NY A04054
Requires retail licensees for on-premises consumption of alcohol and adult-use on-site consumption of cannabis licensees have opioid antagonists to be administered to patrons, staff or individuals on premises of such establishment.
summary
Introduced
01/31/2025
01/31/2025
In Committee
01/31/2025
01/31/2025
Crossed Over
Passed
Dead
Introduced Session
2025-2026 General Assembly
Bill Summary
AN ACT to amend the alcoholic beverage control law and the cannabis law, in relation to requiring certain businesses in which alcohol or cannabis is consumed to have opioid antagonists
AI Summary
This bill requires retail establishments that serve alcohol or provide on-site cannabis consumption to keep opioid antagonists (such as naloxone or Narcan) on hand for potential medical emergencies. Specifically, the bill mandates that bars, restaurants with liquor licenses, and cannabis consumption sites must have these medications available to be administered to patrons, staff, or any individuals on the premises who may be experiencing an opioid overdose. An opioid antagonist is defined as a medication approved by the Department of Health and the Federal Food and Drug Administration that can neutralize or reduce the effects of opioids in a person's body. The bill will go into effect 90 days after it becomes law, which aims to help prevent opioid-related deaths by ensuring quick access to life-saving medication in locations where drug or alcohol consumption occurs.
Committee Categories
Business and Industry
Sponsors (3)
Last Action
referred to economic development (on 01/31/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.nysenate.gov/legislation/bills/2025/A4054 |
| BillText | https://assembly.state.ny.us/leg/?default_fld=&bn=A04054&term=2025&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y#A04054 |
Loading...